Rickets
1. Nuralieva Altynay Topchubaevna
2. Swapnil Dhanore
Altaf Raja
Afroz Khan
(1. Lecturer, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic.
2. Students, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic.)
Abstract:
Rickets, a skeletal disorder characterized by impaired mineralization of growing bones, continues to pose significant challenges in paediatric healthcare worldwide. This intricate condition stems from a myriad of factors including environmental influences, genetic predispositions, and nutritional deficiencies. This comprehensive abstract provides an in-depth exploration of rickets, elucidating its multifaceted etiologic, pathogenesis, clinical manifestations, diagnostic strategies, treatment modalities, and preventive measures. Drawing upon a diverse array of research findings and clinical insights, this abstract underscore the complex interplay between vitamin D metabolism, calcium and phosphate homeostasis, and regulatory hormonal pathways in the development and progression of rickets. Through a thorough examination of these key aspects, healthcare professionals can enhance their understanding of rickets and optimize management strategies to mitigate its impact on paediatric health. Moreover, this abstract emphasizes the importance of collaborative efforts among researchers, clinicians, policymakers, and community stakeholders in addressing the socioenvironmental determinants and implementing evidence-based interventions to prevent and manage rickets effectively. Keywords: vitamin D, phosphate homeostasis, calcium, Rickets.
INTRODUCTION:
The ancient skeletal disease known as rickets serves as a sobering reminder of the complex interplay between environmental influences and human health. Although it was common in the past, rickets continues to be a problem in modern medicine, presenting different symptoms to different groups of people in different places. This introduction provides a starting point for exploring the depths of rickets,going beyond simple historical reflection to shed light on the condition’s current state. This article attempts to by exploring the etiology, pathophysiology, clinical symptoms, subtleties of diagnosis, treatment subtleties, and preventative imperatives. Unravel the complexities of rickets and underscore the imperative for concerted action in addressing this multifaceted skeletal disorder. As we embark on this journey of understanding, it becomes apparent that rickets is not merely a vestige of the past but a dynamic entity entwined with the fabric of modern healthcare, calling for interdisciplinary collaboration and innovative approaches to combat its enduring presence.
The disease rickets is widespread throughout the world (Craviari T, 2017, et.al; p.112-121, Carpenter TO,2012, et.al p.17101). has a significant impact on children’s and adolescents’ development, growth, and health. It is caused by anomalies in the growth plate cartilage, which primarily impact longer bones. As a result, there is inadequate mineralization, poor bone formation, and skeletal malformations such knock-knees and bow-legs (Jagtap VS, 2012, et.al p. 177-182). Since calcium and phosphorus are necessary for healthy bone formation and mineralization, deficits in these elements are typically the result (Sahay M, 1991, et.al p. 164-176). This review article explores and examines various forms of rickets and the best ways to treat them.
CONTEXT:
In the past, rickets was common during the industrial revolution and mostly affected children who lived in impoverished metropolitan areas. The discovery of vitamin D and its significance for bone health transformed our comprehension of rickets by emphasizing the value of exposure to sunlight and dietary sources of this nutrient. But even with advances in medical science and public health initiatives, rickets continues to be a serious health concern in some parts of the world for particular people. Creating focused interventions and strategies to fight rickets requires an understanding of the socioeconomic, cultural, and environmental elements influencing its incidence.
ETIOLOGY & PATHOGENSIS
The following factors can contribute to vitamin D deficiency: latitude, season, and exposure to sunlight. Dietary factors: The importance of diet, including foods like fatty fish, dairy products with added vitamin D, andsupplementation methods, in supplying enough vitamin D. Cells that play a variety of specialized tasks during the process of bone development make up bones. Osteoblasts are the cells that produce bones; they secrete the extracellular matrix and mineralize the osteoid. On the other hand, osteoclasts degrade the bone matrix as a result of disease, aging, or remodelling. The osteoid, the organic component of the bone matrix, needs to be mineralized by calcium salts in order for the bone to mature. This process is impeded in rickets, which leads to the accumulation of osteoid beneath the growth plate and eventually softens the bone over time (Sahay M, 1991, et.al, pp. 164-176). Phosphopenic and calcipenic rickets are the two main subgroups (Jagtap VS, et.al, 2009, p. 392-401).
Phosphorus is a structural element that is present in all bodily tissues and is essential for the mineralization of bone. According to (Goldsweig BK, et.al (2015), P. 88-97), both calcium and phosphorus maintain the bone in a healthy, functional state. Increased renal excretion of phosphate is typically the cause of the problem in phosphopenic/hypophosphatemia rickets.
Genetic Variations: These refer to genetic variants that impact vitamin D metabolism and receptor function, which in turn lead to differences in the susceptibility to insufficiency. The impact of a mother’s vitamin D status during pregnancy the development of the foetus’s bones and the likelihood neonatal rickets are considered maternal factors. Environmental Toxins: Impacts on vitamin D metabolism and bone health caused by environmental contaminants such metals and endocrine disrupting substances.
Mechanisms of Pathophysiology:
Calcipenic rickets, as the name suggests, happens primarily because of a lack of calcium, which is most commonly due to a low availability or defective functioning of vitamin D in the body. Hence, calcipenic rickets can occur due to severe vitamin D deficiency (nutritional), inability to form either 25- hydroxyvitamin D (as in liver failure/drug intoxication; e.g., phenytoin) or 1,25-dihydroxy vitamin D (as in chronic kidney disease), or due to end-organ resistance to 1,25-dihydroxy vitamin D (Jagtap VS, et.al, 2009, p. 392-
401). As a result, calcium absorption in the gut is decreased, which in turn increases parathyroid hormone (PTH) secretionby the parathyroid gland. PTH aims to preserve blood calcium levels by activating bone resorption mediated by increasing RANKL by osteoblasts, (ii) decreasing renal calcium loss, and (iii) increasing renal phosphate loss by internalization and subsequent degradation of sodium-dependent phosphate cotransporter protein (NaPi-2a and NaPi-2c), which decreases tubular phosphate reabsorption (Mughal MZ, 2011, P. 291-299). (The common pathway in the development of rickets in both calcipenic and phosphopenic forms is reduced phosphate concentration. (Carpenter TO, et.al, 2017, p. 17101; Sabbagh Y, et.al, 2005, p. 9637-9642).
Metabolism of Vitamin D: - Synthesis and Activation: Vitamin D is biosynthesised in the skin, converted in the kidneys to its active form, calcitriol, and regulated by fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH)
- Calcium and Phosphate Homeostasis: By interacting with parathyroid hormone and FGF23, vitamin D has a role in improving intestinal calcium absorption and preserving serum calcium and phosphate levels.
- Skeletal Mineralization: Vitamin D deficiency's effects on bone mineralization result in inadequate osteoid development, inadequate matrix mineralization, and the distinctive skeletal abnormalities associated with rickets.
Epidemiology:
Worldwide, rickets is still a prevalent illness. Even though the prevalence of rickets is estimated globally, it is limited due to a lack of essential data, such as dietary intake of vitamin D, particularly in children in non- industrialized countries. Recent research suggest that the prevalence of rickets is rising (Callaghan, et.al, 2006, 606-607; Thacher, T.D, et.al,2013, p. 176-183).
Worldwide, nutritional rickets continues to be the most prevalent form and the leading cause of childhood bone disease (Özkan, B. et.al, 2010, p. 137-143). Early in the new millennium, the United States had incidence estimates of 24.1 cases per 100,000 people for nutritional rickets, up from (Callaghan, et.al, 2006, p. 606-607). 2 cases per 100,000 in the early 1980s (Thacher, T.D, et.al, 2013, p. 176-183). As of right now, reports from Europe and the United States indicate case rates ranging from 2.9 to 27 per 100,000 people (Thacher, T.D, et.al,2013, p. 176-183).
But low- and middle-income nations, particularly those in the Middle East, Africa, and the Indian subcontinent,appear to have higher rates of nutritional rickets (Creo, A.L, et.al,2016, p. 84-98).
2. Research from Asia indicates that nutritional rickets is still very common; in rural central Tibet, over 30% of children 0-5 years old showed at least one clinically observed symptom of the disease (Rooze, S, et.al, 2012, p.1185-1191). Geographic variations exist in the genesis of nutritional rickets, despite its global prevalence. The most frequent cause, particularly in temperate nations, is a lack in vitamin (Creo, A.L, et.al, 2016, p. 84-98). However, poor dietary Ca consumption also plays a critical role in certain contexts, such as low- and middle-income countries in Asia and Africa (Jones, K.D.J, et.al, 2018, p.12452). There are currently minimal epidemiological data available, and other heritable forms of rickets are exceedingly rare.
Types;
Type 1 Rickets Dependent on Vitamin D
Vitamin D-dependent type 1 rickets (VDDR I) is a rare disease that often strikes during the first year of life. Homozygous inactivating mutations in the CYP27B1 gene cause an autosomal recessive illness of vitamin D metabolism by impairing the production of the enzyme 1 alpha-hydroxylase, which in turn causes low serum levels of the active metabolite calcitriol (Takeda E, et al.1997. p. 508-513; Ting TH, et.al, 2016, p.354-356).
Even when the patient is getting enough vitamin D, specific clinical signs of rickets include growth failure, hypotonia, rachitic rosary, genu valgum, and increased susceptibility to fractures. In contrast to nutritional rickets, (Takeda E, et al.1997. p. 508-513). The laboratory results would typically indicate low calcium, low phosphate, raised PTH, and high alkaline phosphatase. They would also typically reveal low levels of vitamin C and normal to high levels of 25-hydroxyvitamins. (Takeda E, et al.1997. p. 508- 513; Holick MF.
As predicted, these kids react better to physiologic dosages of calcitriol or la-hydroxyvitamin D (1-2 mg) than they do to high cholecalciferol levels every day). It is important to maintain an adequate daily intake of dietary calcium (30-75 mg/kg of elemental calcium). (Sahay M, et.al, 2013; S35-S44).
Radiological healing usually happens six to eight weeks into treatment. The potential side effects of hypercalcemia, hypercalciuria, and nephrocalcinosis resulting fromcalcitriol medication should be closely observed in these children. (Sahay M, et.al, 2013, S35-S44). It is recommended to conduct routine blood work (serum creatinine and calcium phosphate), urine examination for urine creatinine and calcium ratio, and renal ultrasound examination.
- Type 2 Rickets Dependent on Vitamin D;
Hereditary vitamin D-resistant rickets, also known as VDDR type 2 (VDDR II), is an uncommon condition that also affects infants. Condition that is autosomal recessive and is brought on by a vitamin D receptor malfunction in calcitriol (Takeda E, et al.1997. p. 508-513). The body becomes insensitive to calcitriol as a result of the deficiency. (Takeda E, et al.1997. p. 508-513)
Early-life symptoms of VDDR II in children include hypocalcemia, rickets, seizures, growth failure, hypoplasia of the enamel, and dental cavities. Alopecia, a measure of the severity of the disease, also happens in two-thirds of cases as a result of keratinocytes’ loss of vitamin D receptor activation. (Sahay M, et.al, 2013; S35-S44; Forghani N, et.al, 2010, p.843-850).
High serum levels of alkaline phosphatase, PTH, hypophosphatemia, hypocalcitriol, and hypophosphatemia are all revealed by the laboratory testing (Takeda E, et al.1997.
VDDR II and VDDR I are distinguished from one another by
Low 1,25 dihydroxy vitamin D levels, among which the levels are always usually high.
Rickets caused by autosomal dominant hypophosphatemia; The beginning age of autosomal dominant hypophosphatemic
Rickets varies, and its penetrance is incomplete. The flaw is an activating mutation that causes phosphaturia in FGF-23. (White Ke, et.al., 2001; p. 2079- 2086). Furthermore, research has demonstrated that an iron deficit causes the FGF-23 gene to express itself more. (Imel EA, et.al, 2020, p. 231-238). In humans and animals with autosomal dominant hypophosphatemia rickets mutation, elevated levels of FGF-23 and hypophosphatemia were linked to iron deficiency. (Imel EA, et.al, 2020; p. :231-238). Two groupings based on the age of presentation exist. One resembles X-linked dominant hypophosphatemic rickets and manifests in childhood. The other subgroup has no deformity but bone pain, weakness, and faux fractures during adolescence or maturity.
Clinical Manifestations:
Early Symptoms and Signs:- development Retardation: Slow development and small stature, indicating a problem with bone mineralization and growth.
Muscular Weakness: This condition is characterized by proximal muscular weakness, which makes it difficult to move from a sitting position, climb stairs, or carry out other motor duties.
Irritability: Pain and discomfort in the musculoskeletal system have been linked to behavioural abnormalities such as irritability, restlessness, and poor sleep quality.
Skeletal Deformities: - Bowing of Legs: Genu varum, which is defined by the lower limbs curving outward, and genu valgum, which is characterized by the inward curvature that results from faulty growth plate mineralization.
Cage resulting from an enlargement of the costochondral joints, indicating the severity of rickets.
- Cranial abnormalities: Typical skull abnormalities include frontal bossing, delayed fontanelle closure, and softening of the skull bones.
Rickets is characterized by abnormalities of the bones. Their maximum frequency has been documented between the ages of 4 and 12 months, with appearances occurring before the age of 18 months on average. The regions primarily impacted are those with rapid bone growth, such as long bone epiphyses and costochondral junctions.
The sorts of bone deformities are determined by the child’s limb weight-bearing patterns (Lambert, A.S 2018, p. 455-476). While knocking knees (genu valgum) or bow legs (genu varum) are more common in toddlers, forearm abnormalities are more common in infants who are crawling (Mughal, M.Z , 2011, p. 291-299). Adolescents rarely exhibit florid indicators of rickets, which typically present as nebulous symptoms like headache and lower limb pain.
Diagnostic Approaches:
Lab Research:
Serum Biomarkers: To evaluate vitamin D status and mineral metabolism, serum 25-hydroxyvitamin D levels, calcium, phosphate, alkaline phosphatase, and parathyroid hormone are measured.
Hereditary testing: This helps diagnose hereditary types of rickets by identifying mutations in genes related to receptor function, vitamin D metabolism, and phosphate transporters.Imaging with radiography
- X-ray studies: assessment of skeletal alterations, such growth plate broadening, metaphyseal cupping, and fraying; identification of Looser zones (pseudo fractures) suggestive underlying bone pathology.
For Phvsical Exam:
- The doctor gently examines the child’s bones, checking abnormalities
Specific areas of focus include:
- Skull: babies with rickets may
- Have softer skull bones
- Legs: exaggerated bowing of the legs is common
- And delayed closure of soft spots (fontanels).
- Chest: rib cage abnormalities can cause breastbones to protrude
- Wrist and ankles: rickets often leads to larger or
- Thicker wrists and ankles
- X-rays: these reveal bone deformities
- Blood and urine tests: confirm the diagnosis and monitor treatment progress
- Bone Densitometry: This technique uses dual-energy absorptiometry (DXA) scanning to measure bone mineral density and evaluate the state of the bones. It also helps
Guide treatment decisions and track therapeutic response. Findings from radiography – Since there is a higher mineral demand at the growth plates of quickly expanding bones, this is where rickets alterations are most visible. As a result, the distal ulna is the upper limb region that most clearly displays the initial indications of compromised mineralization. The metaphysis above and below the knees are the most useful sites in the lower extremities.
The epiphyseal/metaphyseal interaction The expansion of the epiphyseal plate and the disappearance of the zone of provisional calcification at the epiphyseal/metaphyseal junction are the first indications of rickets. This area gets more disordered as the disease worsens, exhibiting stippling, cupping, splaying, and the development of cortical spurs. The epiphyseal bone centres may not form right away or they may be tiny, osteopenic, and poorly defined (Alan E Oestreich, 2004, p.119-28).
Treatment Plans:
Interventions related to nutrition: Vitamin D Supplementation: Dosage modifications are dependent on age, weight, and clinical response. Vitamin (cholecalciferol) or vitamin D2 (ergocalciferol) areadministered based on serum levels and the severity of deficiency.
Calcium and Phosphate Replacement: To address mineral imbalances and promote bone mineralization, oral supplements including calcium carbonate or citrate in addition to phosphate salts are recommended.
Medicinal Therapy:
- Calcitriol Administration: By giving out calcitriol, active vitamin D metabolite, poor renal conversion can avoided, and intestinal calcium absorption and skeletal mineralization can be encouraged.
Bisphosphonate Therapy: Use of bisphosphonates, such as alendronate or pamidronate, to inhibit bone resorption and enhance bone density in severe cases of rickets with persistent skeletal deformities.
Surgical interventions include orthopaedic operations
Such as guided growth procedures, limb reconstruction surgeries, and corrective osteotomies to treat skeletal abnormalities and improve functional results in instances that are refractory
- Dental Interventions: To address rickets-related dental abnormalities and avoid long-term consequences, orthodontic therapy, dental restorations, and preventative dental care are recommended.
Preventive actions: Public health campaigns:
- Sunlight Exposure Promotion: To improve endogenous vitamin D synthesis and avoid deficiency, education initiatives are being launched to promote safe sun practices and outdoor activities.
Dietary fortification programs: These mandate the addition of calcium, phosphate, and vitamin D to staple foods in order to ensure sufficient nutrient intake and lower the incidence of nutritional rickets.
- Maternal and Child Health Programs: Guidelines for
Infant vitamin D supplementation to prevent neonatal and infantile rickets, breastfeeding assistance, and prenatal counselling on maternal vitamin D supplementation.
Interventions in Schools: - Health Education Programs: Including instruction on bone health in school curricula to raise awareness among students, parents, and teachers of the value of a healthy diet, exposure to sunlight, and physical activity in preserving skeletal health. Screening Initiatives: Providing early identification and
Intervention to prevent skeletal abnormalities and growthdeficits, school-age children should undergo periodic Screening for vitamin D deficiency and rickets risk factors.
Conclusion:
A multifactorial skeletal condition called rickets embodies the complex interaction of genetic susceptibility, environmental circumstances, and diet. Even after being recognized for centuries, rickets continues to be a major public health concern, requiring a comprehensive strategy that includes prevention, early diagnosis, and thorough management techniques. The complexity of this ailment is highlighted by the clarification of its etiology, pathophysiology, clinical presentations, diagnostic techniques, therapeutic alternatives, and prevention measures.
In order to address the multifaceted character of rickets and its significant influence on paediatric health, coordinated measures are needed going forward. Effective solutions for rickets prevention, early detection, and optimal management require collaboration among healthcare professionals, researchers, policymakers, and community partners. Prioritizing education and awareness campaigns for at-risk populations is important in public health programs. These campaigns should highlight the significance of supplementing practices, dietary modifications, and sunlight exposure.
In addition, continuous research initiatives are essential for expanding our comprehension of the intricate molecular pathways that underlie the pathophysiology of rickets and for locating new targets for treatment. Personalized medicine techniques and genetic screening have the potential to optimize clinical outcomes and reduce long- term consequences by customizing treatment plans for each patient.
In conclusion, eradicating rickets requires multifaceted approach that addresses socioeconomic disparities, promotes public health education, fosters interdisciplinary collaboration, and advances scientific innovation. By collectively addressing the root causes and implementing evidence-based interventions, we can mitigate the burden of rickets and ensure optimal skeletal health for future generations. Let us unite our efforts in the pursuit of a world where rickets is relegated to the annals of history, and every child enjoys the gift of strong and healthy bones.
REFERENCES;
[1.]Sahay M, Sahay R. Renal rickets-practical approach. Indian Endocrinol Metab. 2013;17:S35-S44
[2.]Craviari T, Pettifor JM, Thacher TD, Rickets: an overview and future directions, with special reference to Bangladesh. A summary of the Rickets Convergence Group meeting, Dhaka, 26-27 January, 2006. Health Popul Nutr. 2008;26:112-121.
[3] Takeda E, Yamamoto H, Taketani Y, Vitamin D-dependent rickets type I
[ 4 ]And type II. Acta Paediatr Jpn. 1997;39:508-513. 38. Alan E Oestreich, 2004
[5]pubmed.ncbi.nlm.nih.gov/14689243/ Callaghan, A.L.; Moy, R.J.; Booth, I.W.; Debelle, G.; Shaw, N.J. Incidence of symptomatic vitamin D deficiency. Arch. Dis. Child. 2006, 91, 606-607. [Google Scholar] [CrossRef] [Green Version]
[6] Carpenter TO, Shaw NJ, Portale AA, Rickets. Nat Rev Dis Primers. 2017;3:17101
[7]Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor Rickets. Nat Rev Dis Primers. 2017; 3: 17101. Doi:10.1038/nrdp.2017.101 Chesney RW, Carpenter TO, Seely BL. Nutritional Rickets: An Old Disease Returns. Pediatr Ann. 1996; 25(5): 292-302. Doi:10.3928/0090- 4481-19960501-10
[8] Choudhury S, Jebasingh KF, Ranabir S, Familial vitamin D resistant rickets: end-organ resistance to 1,25-dihydroxyvitamin D. Indian
[9.]Endocrinol Metab. 013;17:S224-S227 Creo, A.L.; Thacher, T.D.; Pettifor, J.M.; Strand, Fischer, P.R. Nutritional rickets around the world: An update. Paediatr. Int. Child. Health 2016, 37, 84-98. [Google Scholar] [CrossRef]
[10]Forghani N, Lum C, Krishnan S, Two new unrelated cases of hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from the same novel nonsense mutation in the vitamin D receptor gene. J Pediatr Endocrinol Metab. 2010;23:843-850
[12] Goldsweig BK, Carpenter TO. Hypophosphatemic rickets: lessons disrupted FGF23 control of phosphorus homeostasis. Curr Osteoporos Rep. 2015;13:88-97
[13] Harinarayan CV. Vitamin D deficiency in children and adolescents Rickets in the Indian subcontinent: causes, clinical features and management. In: Zaidi M, Dusso AS, Turner RT, eds. Vitamin Oxidative Stress, Immunity, and Aging. 2rd ed. Boca Raton, FL: Press/Taylor & Francis; 2012: 329-340. Doi:10.1201/b13125-29
[14] Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062-2072. 39.
[15] Holick MF. Vitamin D Deficiency. N Engl J Med. 2007; 357 (3): 266- 281. Doi:10.1056/NEJMra070553
[16] Imel EA, Liu Z, Coffman M, Oral iron replacement normalizes fibroblast growth factor 23 in iron-deficient patients with autosomal Dominant hypophosphatemic rickets. J Bone Miner Res. 2020;35:231-238 [17] Jagtap VS, Sarathi V, Lila AR, Hypophosphatemic rickets. Indian J
[17]]Endocrinol Metab. 2012;16:177-182. Jones, K.D.J.; Hachmeister, C.U.; Khasira, M.; Cox, Schoenmakers, I.; Munyi, C.; Nassir, H.S.; Hünten-Kirsch, Prentice, A.; Berkley, J.A.